92 related articles for article (PubMed ID: 4075316)
1. Cellular basis for the inefficacy of 5-FU in human colon carcinoma.
Drewinko B; Yang LY
Cancer Treat Rep; 1985 Dec; 69(12):1391-8. PubMed ID: 4075316
[TBL] [Abstract][Full Text] [Related]
2. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of in vitro assays for the cytotoxic effect of anticancer drugs].
Li XT; Lin C; Li PY
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):184-6. PubMed ID: 3743346
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay.
Park JG; Kramer BS; Steinberg SM; Carmichael J; Collins JM; Minna JD; Gazdar AF
Cancer Res; 1987 Nov; 47(22):5875-9. PubMed ID: 3664487
[TBL] [Abstract][Full Text] [Related]
5. Mixed function oxidase activities of established human colon carcinoma cell lines in the activation of cyclophosphamide.
Moskwa PS; Vadi H; Drewinko B
Cancer Res; 1985 Nov; 45(11 Pt 1):5447-51. PubMed ID: 4053018
[TBL] [Abstract][Full Text] [Related]
6. [In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Nagai S; Kamiya H; Sato K; Sakai K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2981-6. PubMed ID: 3094455
[TBL] [Abstract][Full Text] [Related]
7. [Progress in experimental chemotherapy of colorectal cancer].
Scheithauer W
Acta Med Austriaca; 1987; 14(5):118-24. PubMed ID: 3439421
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
9. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
Sobrero AF; Bertino JR
Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
[TBL] [Abstract][Full Text] [Related]
10. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
11. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS
Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
[TBL] [Abstract][Full Text] [Related]
12. [Colony assay for clinical application].
Ichihashi H; Sako T; Akiyama S
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1560-5. PubMed ID: 3927845
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
16. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
17. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells.
Zou K; Ju JH; Xie H
Acta Pharmacol Sin; 2007 May; 28(5):721-30. PubMed ID: 17439729
[TBL] [Abstract][Full Text] [Related]
19. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
20. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
Sutton JE; Roos IA; Hillcoat BL
Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
